Deep Learning for Diabetes: A Systematic Review
- PMID: 33232247
- DOI: 10.1109/JBHI.2020.3040225
Deep Learning for Diabetes: A Systematic Review
Abstract
Diabetes is a chronic metabolic disorder that affects an estimated 463 million people worldwide. Aiming to improve the treatment of people with diabetes, digital health has been widely adopted in recent years and generated a huge amount of data that could be used for further management of this chronic disease. Taking advantage of this, approaches that use artificial intelligence and specifically deep learning, an emerging type of machine learning, have been widely adopted with promising results. In this paper, we present a comprehensive review of the applications of deep learning within the field of diabetes. We conducted a systematic literature search and identified three main areas that use this approach: diagnosis of diabetes, glucose management, and diagnosis of diabetes-related complications. The search resulted in the selection of 40 original research articles, of which we have summarized the key information about the employed learning models, development process, main outcomes, and baseline methods for performance evaluation. Among the analyzed literature, it is to be noted that various deep learning techniques and frameworks have achieved state-of-the-art performance in many diabetes-related tasks by outperforming conventional machine learning approaches. Meanwhile, we identify some limitations in the current literature, such as a lack of data availability and model interpretability. The rapid developments in deep learning and the increase in available data offer the possibility to meet these challenges in the near future and allow the widespread deployment of this technology in clinical settings.
Similar articles
-
Multi-Modal Deep Learning Diagnosis of Parkinson's Disease-A Systematic Review.IEEE Trans Neural Syst Rehabil Eng. 2023;31:2399-2423. doi: 10.1109/TNSRE.2023.3277749. Epub 2023 May 25. IEEE Trans Neural Syst Rehabil Eng. 2023. PMID: 37200116
-
Data-driven modeling and prediction of blood glucose dynamics: Machine learning applications in type 1 diabetes.Artif Intell Med. 2019 Jul;98:109-134. doi: 10.1016/j.artmed.2019.07.007. Epub 2019 Jul 26. Artif Intell Med. 2019. PMID: 31383477 Review.
-
Recent trends in diabetes mellitus diagnosis: an in-depth review of artificial intelligence-based techniques.Diabetes Res Clin Pract. 2025 Jun;224:112221. doi: 10.1016/j.diabres.2025.112221. Epub 2025 May 4. Diabetes Res Clin Pract. 2025. PMID: 40328407 Review.
-
Towards Personalized AI-Based Diabetes Therapy: A Review.IEEE J Biomed Health Inform. 2024 Nov;28(11):6944-6957. doi: 10.1109/JBHI.2024.3443137. Epub 2024 Nov 6. IEEE J Biomed Health Inform. 2024. PMID: 39137085 Review.
-
Introduction to Machine Learning, Neural Networks, and Deep Learning.Transl Vis Sci Technol. 2020 Feb 27;9(2):14. doi: 10.1167/tvst.9.2.14. Transl Vis Sci Technol. 2020. PMID: 32704420 Free PMC article.
Cited by
-
Deep learning for blood glucose level prediction: How well do models generalize across different data sets?PLoS One. 2024 Sep 25;19(9):e0310801. doi: 10.1371/journal.pone.0310801. eCollection 2024. PLoS One. 2024. PMID: 39321157 Free PMC article.
-
Artificial intelligence in antidiabetic drug discovery: The advances in QSAR and the prediction of α-glucosidase inhibitors.Comput Struct Biotechnol J. 2024 Jul 6;23:2964-2977. doi: 10.1016/j.csbj.2024.07.003. eCollection 2024 Dec. Comput Struct Biotechnol J. 2024. PMID: 39148608 Free PMC article. Review.
-
A Deep Learning Framework for Automatic Meal Detection and Estimation in Artificial Pancreas Systems.Sensors (Basel). 2022 Jan 8;22(2):466. doi: 10.3390/s22020466. Sensors (Basel). 2022. PMID: 35062427 Free PMC article.
-
Diaproteo: A supervised learning framework for early detection of diabetes mellitus based on proteomic profiles.Digit Health. 2025 Jul 30;11:20552076251362281. doi: 10.1177/20552076251362281. eCollection 2025 Jan-Dec. Digit Health. 2025. PMID: 40755961 Free PMC article.
-
Implementation of five machine learning methods to predict the 52-week blood glucose level in patients with type 2 diabetes.Front Endocrinol (Lausanne). 2023 Jan 20;13:1061507. doi: 10.3389/fendo.2022.1061507. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36743935 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical